Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 110 of 1,261
  1. US 12018135

    Encapsulation by cross-linking of anionic polymers by pH induced dissociation of cation-chelate complexes

    The Regents of the University of California · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  2. US 12018125

    Block-copolymers for the delivery of active agents

    Julius-Maximilians-Universitat Wurzburg · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  3. US 12018327

    Methods and compositions relating to epoxide hydrolase genes

    The Regents of the University of California · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  4. US 12016952

    Methods of preparing a monodisperse oligo(ethylene glycol) reagent composition

    Nektar Therapeutics · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  5. US 12016853

    Methods of treating RBP4 related diseases with triazolopyridines

    Belite Bio, Inc · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  6. US 12016877

    Anticancer compositions and methods for making and using them

    The Regents of the University of California · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  7. US 12016950

    Devices and methods for treating ear pain

    Try This First, Inc. · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  8. US 12017989

    Controlled release pharmaceutical formulations

    United Therapeutics Corporation · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  9. US 12016929

    Lipid formulations for delivery of therapeutic agents

    ARBUTUS BIOPHARMA CORPORATION · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  10. US 12018001

    Pyrimidine cyclohexenyl glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  11. US 12016932

    Gene editing for hemophilia A with improved factor VIII expression

    CRISPR THERAPEUTICS AG · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  12. US 12018011

    Macrocyclic compounds and compositions, and methods of preparing and using the same

    Kura Oncology, Inc. · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  13. US 12018298

    PH20 polypeptide variants, formulations and uses thereof

    HALOZYME, INC. · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  14. US 12017030

    Hydrogen-enhanced transdermal system

    H2 Universe LLC · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  15. US 12018252

    Methods and compositions for identifying neoantigens for use in treating cancer

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  16. US 12018074

    Anti CCL24 (eotaxin2) antibodies for use in the treatment of hepatic diseases

    CHEMOMAB LTD. · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  17. US 12018015

    Methods and compositions for targeting PD-L1

    Aligos Therapeutics, Inc. · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  18. US 12016904

    Treatment of gastrointestinal bleeding in patients with severe von Willebrand disease by administration of recombinant VWF

    Takeda Pharmaceutical Company Limited · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  19. US 12016884

    Adipose derived stem cell exosomes and uses thereof

    United States Government as represented by the Department of Veterans Affairs · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  20. US 12016973

    Methods and systems for augmenting immune system responses

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  21. US 12016908

    Compositions and methods for treating hemoglobinopathies

    Beam Therapeutics Inc. · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  22. US 12016848

    Roflumilast formulations with an improved pharmacokinetic profile

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted Jun 25, 2024 · Expires Jun 20, 2044

    granted
  23. US 2024197727

    SOLID DISPERSIONS COMPRISING AMORPHOUS PIMOBENDAN AND ONE OR MORE STABILIZING POLYMERS

    BOEHRINGER INGELHEIM VETMEDICA GMBH [DE] · Granted Jun 20, 2024 · Expires Jun 15, 2044

    granted
  24. US 12011425

    Hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jun 18, 2024 · Expires Jun 13, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.